Fibroblast activation protein (FAP) has received increasing attention as an oncologic target because of its prominent expression in solid tumors but virtual absence from healthy tissues. Most ...

This year, the tracer principle, a key concept within nuclear medicine, molecular imaging, and radiotheranostics, is marking the centennial anniversary of its discovery ([Fig. 1][1]). Although Marie ...

Somatostatin receptor (SSTR) PET has demonstrated a significant improvement over conventional imaging (CI) in patients with neuroendocrine tumors (NETs). SSTR PET should replace 111In-pentetreotide ...

Patients with obstructive hypertrophic cardiomyopathy (HCM) exhibit elevated left ventricular outflow tract gradients (LVOTGs) and appear to have a worse prognosis than those with nonobstructive HCM.

Our aim is to assess the cost-effectiveness of long–axial-field-of-view (LAFOV) versus short–axial FOV (SAFOV) PET/CT systems using international data. Methods: Our model compares equipment and ...

Noninvasive monitoring of immune responses is important for increasing the efficacy of cancer immunotherapy. Although several approaches exist, few methods directly report on T-cell activation. We ...

Reactive oxygen species (ROS) play a pivotal role in many cellular processes and can be either beneficial or harmful. The design of ROS-sensitive fluorophores has allowed for imaging of specific ...

Radiopharmaceutical therapy (RPT) is entering a new era of personalization, driven by advances in molecular imaging, radiopharmaceutical development, and a growing body of clinical evidence linking ...

A 38-y-old man with mixed, nonseminomatous germ cell carcinoma metastatic to the lung, liver, and retroperitoneal lymph nodes was treated with left orchiectomy and 4 cycles of cisplatin, etoposide, ...

251413 Introduction: Recent advances in obesity medicine have revolutionized the treatment of patients with type 2 diabetes mellitus and obesity. One of the most widely used medications in this ...

Despite significant gains in the treatment of metastatic castration-resistant prostate cancer by radioligands targeting prostate-specific membrane antigen (PSMA), 30% of patients never respond to ...

Quantitative 18F-FDG PET is increasingly being recognized as an important tool for diagnosis, determination of prognosis, and response monitoring in oncology. However, PET quantification with, for ...